Stephenson Harwood

Testimonials

Collated independently by Legal 500 research team.

• ‘Stephenson Harwood offer a friendly, tight-knit team who are a pleasure to work with. They attract and keep hold of their high profile clients for a reason.’

• ‘Rob Jacob has extensive experience of trade mark litigation and consistently offers valuable contributions to litigation strategy, keeping an eye on the bigger picture.'

• 'Laura Elliott is very responsive and efficient and has good judgment.’

• ‘The whole team is very responsive. They have good lawyers following each file closely.’

• ‘Rob Jacob is a very experienced lawyer on IP issues, especially the non-traditional trade marks. Always responsive.’

• ‘The Stephenson Harwood team is our go-to partner for IP litigation, and they are someone we always want on our side. From a practical perspective, Stephenson Harwood’s ability to distil complex contentious proceedings into manageable and client-friendly advice allows us to give our clients a real edge in litigation.’

• ‘The whole team is reliable and responsive. Rob Jacob's litigation strategy and coordination is highly recommended, and puts clients at ease. There are no surprises with Rob, and clients always welcome his straight talking and pragmatic approaches to cases.'

• 'Managing associate Joshua Cunnington and associate Laura Elliott are always on hand to offer timely and pragmatic advice, and a seamless service across the team. You are in safe hands with partners or associates.’

Key clients

Work highlights

Lawyers

Next Generation Partners

Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Rob Jacob

Stephenson Harwood

Rob is a partner specialising in both contentious and non-contentious IP issues with a particular focus on trade mark and copyright matters. He has particular expertise in the life sciences, offshore construction and luxury brands sectors. Rob has a masters degree in Chemistry from Imperial College, London and a post-graduate diploma in IP law and practice. He trained and qualified into the IP team at Clifford Chance before joining Stephenson Harwood in 2009 specialising in all intellectual property matters. Rob acted on DataCard Corporation v Eagle Technologies Limited ([2011] EWHC 244 (Pat)) where the firm successfully argued for the extension of trade mark law in relation to post-sale confusion. His other more recently reported cases include: Glaxo Wellcome UK Limited v Sandoz Ltd [2017] EWHC 3196 (Ch), Parainen Pearl Shipping Ltd v Kristian Gerhard Skipsrederi AS [2018] EWHC 2628 (Pat), Smart Reamer Drilling Systems v NOV Downhole Eurasia [2018] 1265 (IPEC) and Pathway IP Sarl v easyGroup Ltd [2018] EWHC 3608 (Ch). He has also successfully argued that residual goodwill subsists in the NICHOLSON gin brand (UK Decision: Opp 0520-14) and has successfully convinced OHIM's Board of Appeal that the shape of GSK's DISKUS inhaler was distinctive (R2074/2013-2). On the non-contentious side, Rob's highlights include working on the public takeover of Biocompatibles plc by BTG plc, the US$3.8 billion sale of Piramal Enterprises' domestic formulations division to US pharmaceuticals giant Abbott, the acquisition of the worldwide rights to Florbetaben (a pioneering molecular imaging product for the diagnosis of early Alzheimer's disease) from Bayer Pharma AG and the US$220 million acquisition of EKOS corporation. Rob is a recommended lawyer in the Legal 500 UK directory for intellectual property and pharmaceuticals and biotechnology with "notable strengths in trade mark work". Rob has been described as “a very brainy guy who thinks deeply about his cases. He is always stress-testing and playing devil’s advocate to be as well prepared as possible. He is unflappable and his measured manner is very reassuring.” (WTR 1000, 2019) Rob also wrote the intellectual property chapter of the book Offshore Construction Law and Practice published by Informa Law from Routledge.